- Applied Economics
- Public Health
- Health Economics
- +۵ مورد دیگر
Professor Richard De Abreu Lourenco is affiliated with the University of Technology Sydney (UTS) as a faculty member in the Faculty of Health , specifically within the Centre for Health Economics Research and Evaluation (CHERE) since 2024. Previously, he held academic roles at UTS including Associate Professor (2018-2023), Senior Research Fellow (2016-2018), and Research Fellow (2013-2016). His non-academic career includes leadership roles at Covance (2006-2013) and Novartis Pharmaceuticals (2001-2006). Education: PhD, University of Technology Sydney (2017) Master of Economics, University of Sydney (1997) Bachelor of Economics, Murdoch University (1992) Research Focus: His work spans applied economic evaluations , specialty health economics (particularly oncology/haematology ), patient preference modeling , and priority setting in healthcare . He explores cost-effectiveness of emerging therapies (CAR-T, SABR radiotherapy), health technology assessment (HTA) , and value frameworks for high-cost treatments . Recent Trends: Recent publications analyze access pathways for rare disease drugs , methodological challenges in discrete choice experiments , cost-effectiveness of radiotherapy vs. ablation , and genetic risk stratification in endocrine tumors . Collaborative work spans oncology , public health policy , and diagnostic testing preferences . Supervision & Grants: Available for Masters and PhD supervision . Leads funded research projects including generative AI in pharmaceutical evaluation , digital health for culturally diverse prostate cancer patients , and economic frameworks for high-cost therapies . Collaborates with institutions like Novartis , Covance , and Cancer Australia .










